Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Country / region: United States Clear all

193 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20206
202119
202229
202353
202444
202529
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Recruiting46
Active, not recruiting19
Unknown status10
Terminated8
Withdrawn6
Enrolling by invitation6
Not yet recruiting6
Suspended2
No longer available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development11
Icahn School of Medicine at Mount Sinai10
Duke University8
Kanecia Obie Zimmerman5
Massachusetts General Hospital5
Beth Israel Deaconess Medical Center4
Columbia University4
Mayo Clinic4
University of California, Los Angeles4
Vanderbilt University Medical Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome193
COVID-1963
Fatigue15
Mental Fatigue13
Cognitive Dysfunction12
Fatigue Syndrome, Chronic11
Postural Orthostatic Tachycardia Syndrome9
Dyspnea7
Anosmia6
Autonomic Nervous System Diseases6

Trials

Showing 1 to 25 of 193. Each trial links to its page on Pharma Observatory.

93 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.